151 related articles for article (PubMed ID: 8161790)
1. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia.
Miyauchi J; Asada M; Sasaki M; Tsunematsu Y; Kojima S; Mizutani S
Blood; 1994 Apr; 83(8):2248-54. PubMed ID: 8161790
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.
Cogswell PC; Morgan R; Dunn M; Neubauer A; Nelson P; Poland-Johnston NK; Sandberg AA; Liu E
Blood; 1989 Dec; 74(8):2629-33. PubMed ID: 2684296
[TBL] [Abstract][Full Text] [Related]
3. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I
Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802
[TBL] [Abstract][Full Text] [Related]
5. Analysis of neurofibromatosis type 1 gene mutation in juvenile chronic myelogenous leukemia.
Watanabe I; Horiuchi T; Hatta N; Matsumoto M; Koike K; Kojima S; Ohga S; Fujita S
Acta Haematol; 1998; 100(1):22-5. PubMed ID: 9691142
[TBL] [Abstract][Full Text] [Related]
6. Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia.
LeMaistre A; Lee MS; Talpaz M; Kantarjian HM; Freireich EJ; Deisseroth AB; Trujillo JM; Stass SA
Blood; 1989 Mar; 73(4):889-91. PubMed ID: 2645949
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia.
Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T
Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia.
Sheng XM; Kawamura M; Ohnishi H; Ida K; Hanada R; Kojima S; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
Leuk Res; 1997 Aug; 21(8):697-701. PubMed ID: 9379676
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML).
Lau RC; Squire J; Brisson L; Kamel-Reid S; Grunberger T; Dubé I; Letarte M; Shannon K; Freedman MH
Leukemia; 1994 May; 8(5):903-8. PubMed ID: 8182949
[TBL] [Abstract][Full Text] [Related]
10. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
Kurosawa M
Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
[TBL] [Abstract][Full Text] [Related]
12. Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia.
Collins SJ; Howard M; Andrews DF; Agura E; Radich J
Blood; 1989 Mar; 73(4):1028-32. PubMed ID: 2645946
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
[TBL] [Abstract][Full Text] [Related]
14. Infrequent ras activation in chronic myelogenous leukemia (CML): activating 61st codon mutation in the CML-derived cell line, IM-9.
Needleman SW; Gutheil JC; Kapil V; Mane SM
Leukemia; 1989 Nov; 3(11):827-9. PubMed ID: 2682048
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.
Kalra R; Paderanga DC; Olson K; Shannon KM
Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098
[TBL] [Abstract][Full Text] [Related]
17. [Hereditary hematopoietic malignancy with emphasis of juvenile chronic myelogenous leukemia and 7 monosomy syndrome].
Hayashi Y
Nihon Rinsho; 1995 Nov; 53(11):2737-41. PubMed ID: 8538036
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
[TBL] [Abstract][Full Text] [Related]
19. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing.
Ahuja HG; Foti A; Bar-Eli M; Cline MJ
Blood; 1990 Apr; 75(8):1684-90. PubMed ID: 2183888
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.
Gaidano G; Guerrasio A; Serra A; Rege-Cambrin G; Saglio G
Leukemia; 1994 Apr; 8 Suppl 1():S27-9. PubMed ID: 8152300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
